Company: SPRB
Filing Date: 2025-04-18
Form Type: PRE 14A
Source: 0000950170-25-055856
Chunk: 22

Company: SPRUCE BIOSCIENCES, INC.
Filing Date: 2025-04-18
Form: PRE 14A
Chunk 22
---
-Ko          |     X |              |                                     |
| Bali Muralidhar, M.D., Ph.D.  |       |            X |                                     |
| Niall O’Donnell, Ph.D. (1)    |     X |              |                                     |
| Camilla V. Simpson, M.Sc. (2) |     X |            X |                                  X* |
| Daniel Spiegelman             |    X* |              |                                   X |
| Kirk Ways, M.D., Ph.D. (3)    |       |              |                                  X* |
| Total meetings in 2024        |     5 |            2 |                                   3 |

<div align='center'>14</div>

* Committee Chairperson

(1) Dr. O’Donnell served on our Board and was a member of the Audit Committee until his resignation on May 22, 2024.

(2) Ms. Simpson became a member of the Audit Committee effective May 22, 2024 and became Chairperson of the Nominating Committee on March 26, 2025

(3) Dr. Ways was the Chairperson of the Nominating Committee until March 26, 2025. Ms. Simpson was appointed Chairperson as of such date.

Each of the committees has authority to engage legal counsel or other experts or consultants, as it deems appropriate to carry out its responsibilities. The Board has determined that each member of each committee meets the applicable Nasdaq rules and regulations regarding “independence” and each member is free of any relationship that would impair his or her individual exercise of independent judgment with regard to the Company.

Below is a description of each committee of the Board.

Audit Committee

The Audit Committee was established by the Board in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), to oversee the Company’s corporate accounting and financial reporting processes and audits of its financial statements. The primary purpose of the Audit Committee is to discharge the responsibilities of the Board with respect to our corporate accounting and financial reporting processes, systems of internal control and financial-statement audits, and to oversee our independent registered accounting firm.

Specific responsibilities of the Audit Committee include:

overseeing our corporate accounting and financial reporting processes;

managing the selection, engagement, qualifications, independence, and performance of a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;

discussing the scope and results